ArticleJournal of neuro-oncology2025

Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer Database.

John Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.